Month: May 2020

Retailers have been particularly hard-hit by the novel coronavirus pandemic. Lockdowns forced store closures, crippling sales. Meanwhile, operating expenses like costly leases continued. Macy’s (NYSE:M) was no exception to the bloodbath. Nothing in the department store’s long history prepared it for the situation it has faced. On Wednesday, Macy’s stock closed at $7.38, after posting a
0 Comments
For years, Apple (AAPL​) has held onto its rank as the most valuable publicly traded company in the world. As of May 27, 2020, its market capitalization is $1.4 trillion. That’s above the likes of other major technology companies, such as Amazon.com (AMZN) and Google (GOOG). Apple shares are trading at $318 a share.  The rise of Apple
0 Comments
CNBC’s Jim Cramer said Wednesday that he thought some stocks were rallying too far too quickly given the high level of unemployment in the United States as the economy tries to pull out of the coronavirus slowdown.  “It’s too ‘happy days are here again,'” Cramer said on “Squawk on the Street.” “It’s just not going
0 Comments
Construction workers build a Toll Brothers home in Boca Raton, Florida. Joe Raedle | Getty Images Check out the companies making headlines after the bell. Virgin Galactic Holdings — The aerospace company’s stock fell 3% in extended trading after fellow space travel company SpaceX had to delay its historic astronaut launch with NASA because of bad weather.
0 Comments
Ford (NYSE:F) stock looks like a good value proposition at today’s price. Why? Even though F stock has no dividend right now, the company will likely restore it soon. Source: Vitaliy Karimov / Shutterstock.com Moreover, Ford’s sales will rebound over the summer and fall. That’s especially true for its F-150 trucks. Keep in mind that
0 Comments
Drug developers like Celgene (CELG) are constantly innovating new medicine to offset the risk of sliding sales tied to expiring patents and that means investors should always be paying attention to when patents are set to end on key, top-selling therapies, such as Celgene’s Revlimid. Read on to learn more about Celgene’s top-selling drugs and the
0 Comments
It’s interesting to see how traders are flocking to certain stocks in the wake of the Covid-19 pandemic. One noteworthy influx of trading volume and analyst coverage has surrounded Inovio Pharmaceuticals (NASDAQ:INO) stock. Source: Ascannio / Shutterstock.com Much of the interest, as you might imagine, involves the company’s prospects of being first to market with a Covid-19
0 Comments